Stay informed with MVRIX’s latest activities and updates
과제
Selected for 2025 Super-gap Company in Biopharma & Materials
April 16, 2025
MVRIX has been officially selected as a 2025 Super-gap Company in Biopharma and Advanced Materials by the National Institute of Toxicological Research.